Fertility control in women with a progestogen released in microquantities from subcutaneous capsules

Horacio Croxatto, Soledad Díaz, Ruth Vera, Martín Etchart, Pablo Atria

Resultado de la investigación: Article

66 Citas (Scopus)

Resumen

Silastic capsules containing megestrol acetate (MA) were implanted subcutaneously in 97 women. Two dosages were studied. There were 160 woman-months of experience for the first group, which had 3 capsules and 595 for the second group, having 4 capsules. There were 5 pregnancies in the first and 4 in the second group. According to indirect signs, approximately 90 per cent of the cycles studied were ovulatory. It appears that the site(s) of action is peripheral to the ovary. Although abnormal bleeding did occur in approximately 30 per cent of the cycles, there were no serious complications associated with the method. The contraceptive effect of a silastic implant containing MA has been demonstrated for the first time in humans.

Idioma originalEnglish
Páginas (desde-hasta)1135-1138
Número de páginas4
PublicaciónAmerican Journal of Obstetrics and Gynecology
Volumen105
N.º7
DOI
EstadoPublished - 1 dic 1969

Huella dactilar

Progestins
Contraception
Megestrol Acetate
Capsules
Contraceptive Agents
Ovary
Hemorrhage
Pregnancy
baysilon

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Citar esto

Croxatto, Horacio ; Díaz, Soledad ; Vera, Ruth ; Etchart, Martín ; Atria, Pablo. / Fertility control in women with a progestogen released in microquantities from subcutaneous capsules. En: American Journal of Obstetrics and Gynecology. 1969 ; Vol. 105, N.º 7. pp. 1135-1138.
@article{3503559d98e14e0cbb744dbe9e8a911a,
title = "Fertility control in women with a progestogen released in microquantities from subcutaneous capsules",
abstract = "Silastic capsules containing megestrol acetate (MA) were implanted subcutaneously in 97 women. Two dosages were studied. There were 160 woman-months of experience for the first group, which had 3 capsules and 595 for the second group, having 4 capsules. There were 5 pregnancies in the first and 4 in the second group. According to indirect signs, approximately 90 per cent of the cycles studied were ovulatory. It appears that the site(s) of action is peripheral to the ovary. Although abnormal bleeding did occur in approximately 30 per cent of the cycles, there were no serious complications associated with the method. The contraceptive effect of a silastic implant containing MA has been demonstrated for the first time in humans.",
author = "Horacio Croxatto and Soledad D{\'i}az and Ruth Vera and Mart{\'i}n Etchart and Pablo Atria",
year = "1969",
month = "12",
day = "1",
doi = "10.1016/0002-9378(69)90140-9",
language = "English",
volume = "105",
pages = "1135--1138",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "7",

}

Fertility control in women with a progestogen released in microquantities from subcutaneous capsules. / Croxatto, Horacio; Díaz, Soledad; Vera, Ruth; Etchart, Martín; Atria, Pablo.

En: American Journal of Obstetrics and Gynecology, Vol. 105, N.º 7, 01.12.1969, p. 1135-1138.

Resultado de la investigación: Article

TY - JOUR

T1 - Fertility control in women with a progestogen released in microquantities from subcutaneous capsules

AU - Croxatto, Horacio

AU - Díaz, Soledad

AU - Vera, Ruth

AU - Etchart, Martín

AU - Atria, Pablo

PY - 1969/12/1

Y1 - 1969/12/1

N2 - Silastic capsules containing megestrol acetate (MA) were implanted subcutaneously in 97 women. Two dosages were studied. There were 160 woman-months of experience for the first group, which had 3 capsules and 595 for the second group, having 4 capsules. There were 5 pregnancies in the first and 4 in the second group. According to indirect signs, approximately 90 per cent of the cycles studied were ovulatory. It appears that the site(s) of action is peripheral to the ovary. Although abnormal bleeding did occur in approximately 30 per cent of the cycles, there were no serious complications associated with the method. The contraceptive effect of a silastic implant containing MA has been demonstrated for the first time in humans.

AB - Silastic capsules containing megestrol acetate (MA) were implanted subcutaneously in 97 women. Two dosages were studied. There were 160 woman-months of experience for the first group, which had 3 capsules and 595 for the second group, having 4 capsules. There were 5 pregnancies in the first and 4 in the second group. According to indirect signs, approximately 90 per cent of the cycles studied were ovulatory. It appears that the site(s) of action is peripheral to the ovary. Although abnormal bleeding did occur in approximately 30 per cent of the cycles, there were no serious complications associated with the method. The contraceptive effect of a silastic implant containing MA has been demonstrated for the first time in humans.

UR - http://www.scopus.com/inward/record.url?scp=0014616406&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(69)90140-9

DO - 10.1016/0002-9378(69)90140-9

M3 - Article

C2 - 5352594

AN - SCOPUS:0014616406

VL - 105

SP - 1135

EP - 1138

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 7

ER -